United States of America based
We accelerate preclinical drug development by applying machine learning to lead generation & optimization.
Using recently-developed machine learning techniques, Reverie Labs has developed best-in-class structure-based predictive models for potency and ADME/PK properties of small molecules. Reverie Labs also develops custom models based on its partners' own datasets.
Reverie Labs has developed a multi-objective molecular optimizer that applies evolutionary algorithms to conceive new molecules that optimize for many ADME/PK properties simultaneously while maintaining potency and synthesizability.
TechnologiesAI Companies (Drug Discovery)
ML-based structure based predictive models for potency and ADMET/PK properties of small molecules
No pipelines published yet
No services posted yet